XRD-0394 is a DNA-PKcs inhibitor. XRD-0394 selectively targets, binds to and inhibits the activity of ATM and DNA-PK. This inhibits ATM-mediated signaling, which may prevent DNA damage checkpoint activation, disrupt DNA damage repair and induce tumor cell apoptosis. XRD-0394 demonstrates significantly enhanced tumor cell kill in the setting of therapeutic ionizing irradiation in vitro and in vivo. XRD-0394 also potentiates the effectiveness of topoisomerase I inhibitors in vitro. In addition, in cells lacking BRCA1/2 XRD-0394 shows single-agent activity and synergy in combination with PARP inhibitors
仅供研究使用。 我们不向患者出售。
| 名称 | XRD-0394 |
|---|---|
| Iupac 化学名称 | N-(5-(7'-fluoro-3'-methyl-2'-oxo-2',3'-dihydrospiro[cyclobutane-1,1'-pyrrolo[2,3-c]quinolin]-8'-yl)-2-(2-(isopropylamino)ethoxy)pyridin-3-yl)methanesulfonamide |
| 同义词 | XRD-0394; XRD0394; XRD 0394 |
| 英文同义词 | XRD-0394; XRD0394; XRD 0394 |
| 分子式 | C26H30FN5O4S |
| 分子量 | 527.61 |
| Smile | CC(NCCOC1=NC=C(C2=C(F)C=C(N=CC(N3C)=C4C5(CCC5)C3=O)C4=C2)C=C1NS(C)(=O)=O)C |
| InChiKey | DFPIFDHNNWOIDD-UHFFFAOYSA-N |
| InChi | InChI=1S/C26H30FN5O4S/c1-15(2)28-8-9-36-24-21(31-37(4,34)35)10-16(13-30-24)17-11-18-20(12-19(17)27)29-14-22-23(18)26(6-5-7-26)25(33)32(22)3/h10-15,28,31H,5-9H2,1-4H3 |
| Cas号 | 2595308-10-2 |
| 相关CAS号 |
| 包装 | 价格 | 库存 | 纯度 | 备货期 |
|---|---|---|---|---|
| 大货 | 询价 | 询价 | 询价 |
| 外观性状 | 类白色固体 |
|---|---|
| 纯度 | 98% Min. |
| 存储 | 0-4℃,可保存几天到几周;-20℃,可保存 几个月。 |
| 可溶性 | 溶于DMSO等有机溶剂 |
| 处理方式 | |
| 运输条件 | 可以在室温下进行运输。 |
| 海关编码 |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Gilmer TM, Lai CH, Guo K, Deland K, Ashcraft KA, Stewart AE, Wang Y, Fu J, Wood KC, Kirsch DG, Kastan MB. A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors. Mol Cancer Ther. 2024 Jun 4;23(6):751-765. doi: 10.1158/1535-7163.MCT-23-0890. PMID: 38588408.